59 related articles for article (PubMed ID: 16116640)
1. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.
Yeh TS; Tseng JH; Chen TC; Liu NJ; Chiu CT; Jan YY; Chen MF
Hepatology; 2005 Sep; 42(3):657-64. PubMed ID: 16116640
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasm of the biliary tract in the caudate lobe of the liver: a case report and literature review.
Zhu X; Ni Q; Wang Q; Ma C; Yang F; Gao H; Zhu H; Zhou X; Chang H; Lu J; Liu F
Front Oncol; 2023; 13():1114514. PubMed ID: 37465111
[TBL] [Abstract][Full Text] [Related]
3. Recent advances of three-dimensional bioprinting technology in hepato-pancreato-biliary cancer models.
Zhuang X; Deng G; Wu X; Xie J; Li D; Peng S; Tang D; Zhou G
Front Oncol; 2023; 13():1143600. PubMed ID: 37188191
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Clinical Significance of MUC5AC in Biliary Tract Cancers.
Benson KK; Sheel A; Rahman S; Esnakula A; Manne A
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672382
[TBL] [Abstract][Full Text] [Related]
5. Mucin-producing Cystic Hepatobiliary Neoplasms: Updated Nomenclature and Clinical, Pathologic, and Imaging Features.
Lee MH; Katabathina VS; Lubner MG; Shah HU; Prasad SR; Matkowskyj KA; Pickhardt PJ
Radiographics; 2021 Oct; 41(6):1592-1610. PubMed ID: 34597230
[TBL] [Abstract][Full Text] [Related]
6. Intraductal papillary mucinous neoplasm of biliary ducts: Literature review and a case report with emphasis on radiological manifestation.
Adibi A; Shabanikia N; Taheri A
J Res Med Sci; 2020; 25():114. PubMed ID: 33912224
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
[TBL] [Abstract][Full Text] [Related]
8. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations.
Nakanuma Y; Uesaka K; Kakuda Y; Sugino T; Kubota K; Furukawa T; Fukumura Y; Isayama H; Terada T
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317146
[TBL] [Abstract][Full Text] [Related]
9. Intraductal papillary neoplasm of bile duct: all rare in one.
Chaturvedi A; Pol MM; Jangra K; Singh P
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168532
[TBL] [Abstract][Full Text] [Related]
10. ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications.
Jin W
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708604
[TBL] [Abstract][Full Text] [Related]
11. Unexpected metastasis of intraductal papillary neoplasm of the bile duct without an invasive component to the brain and lungs: A case report.
Nam NH; Taura K; Kanai M; Fukuyama K; Uza N; Maeda H; Yutaka Y; Chen-Yoshikawa TF; Muto M; Uemoto S
World J Gastroenterol; 2020 Jan; 26(3):366-374. PubMed ID: 31988595
[TBL] [Abstract][Full Text] [Related]
12. Precursors to Cholangiocarcinoma.
Hucl T
Gastroenterol Res Pract; 2019; 2019():1389289. PubMed ID: 31814823
[TBL] [Abstract][Full Text] [Related]
13. CK20 and lymph node involvement predict adverse outcome of malignant intraductal papillary neoplasm of the bile duct.
Shi J; Wan X; Xie Y; Lin J; Long J; Xu W; Liang Z; Sang X; Zhao H
Histol Histopathol; 2020 May; 35(5):449-456. PubMed ID: 31657857
[TBL] [Abstract][Full Text] [Related]
14. Utility of Endoscopic Retrograde Cholangiopancreatography in the Treatment of Intraductal Papillary Neoplasm of the Bile Duct.
Patel N; Goodman A
ACG Case Rep J; 2019 Jul; 6(7):e00122. PubMed ID: 31620522
[TBL] [Abstract][Full Text] [Related]
15. Biliary Intraepithelial Neoplasia in Non-biliary Cirrhosis-Report From 100 Explanted Livers: A Single Center Experience.
Zarei M; Shasaeefar A; Kazemi K; Dehghani M; Malekhosseini SA; Geramizadeh B
Clin Pathol; 2019; 12():2632010X19876934. PubMed ID: 31555761
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.
Nakanuma Y; Kakuda Y; Uesaka K
Gut Liver; 2019 Nov; 13(6):617-627. PubMed ID: 30982236
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous neoplasm of the biliary tract: A precursor lesion to cholangiocarcinoma.
Ritchie DJ; Okamoto K; White SL
Radiol Case Rep; 2019 Apr; 14(4):495-500. PubMed ID: 30815047
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antiproliferative effects of an mTOR inhibitor (rad001) plus gemcitabine on cholangiocarcinoma by decreasing choline kinase activity.
Lin G; Lin KJ; Wang F; Chen TC; Yen TC; Yeh TS
Dis Model Mech; 2018 May; 11(8):. PubMed ID: 29666220
[TBL] [Abstract][Full Text] [Related]
19. Expression and Serum Levels of Mucin 5AC (MUC5AC) as a Biomarker for Cholangiocarcinoma: a Meta-analysis.
Pabalan N; Sukcharoensin S; Butthongkomvong K; Jarjanazi H; Thitapakorn V
J Gastrointest Cancer; 2019 Mar; 50(1):54-61. PubMed ID: 29139058
[TBL] [Abstract][Full Text] [Related]
20. Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct.
Wan X; Shi J; Wang A; Xie Y; Yang X; Zhu C; Zhang H; Wu L; Wang S; Huang H; Lin J; Zheng Y; Liang Z; Sang X; Zhao H
Oncotarget; 2017 May; 8(19):31532-31539. PubMed ID: 28415560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
